Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Biomaterials. 2015 Mar 18;52:426–440. doi: 10.1016/j.biomaterials.2015.02.064

Figure 8.

Figure 8

Maximal torsion strength of tissue engineered periosteum modified allografts transplanting a mixed cell population was significantly increased over unmodified allograft controls, and tissue engineered periosteum modified allografts transplanting either MSCs or osteoprogenitors 9 weeks post-implantation (n=8–10; error bars represent standard error of the mean; p-value of <0.05 indicates significance compared to intact femur (*), autograft (#), or allograft ($)).